Lithium prevents scopolamine-induced memory impairment in zebrafish

被引:40
作者
Zanandrea, Rodrigo [1 ]
Abreu, Murilo S. [1 ,2 ]
Piato, Angelo [3 ]
Barcellos, Leonardo J. G. [1 ,2 ,4 ]
Giacomini, Ana C. V. V. [1 ,2 ,5 ]
机构
[1] Univ Passo Fundo, BR 285, BR-99052900 Passo Fundo, RS, Brazil
[2] Univ Fed Santa Maria, Programa Posgrad Farmacol, Av Roraima,1000 Cidade Univ, BR-97105900 Santa Maria, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Farmacol & Terapeut, Av Sarmento Leite 500-305, BR-90050170 Porto Alegre, RS, Brazil
[4] Univ Passo Fundo, Programa Posgrad Bioexpt, BR 285, BR-99052900 Passo Fundo, RS, Brazil
[5] Univ Passo Fundo, Programa Posgrad Ciencias Ambientais, BR 285, BR-99052900 Passo Fundo, RS, Brazil
关键词
Acetylcholinesterase; Anxiety; Memory; Alzheimer's disease; Cognition; ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE ACTIVITY; MUSCARINIC RECEPTORS; DANIO-RERIO; THERAPEUTICS; CARBONATE; BRAIN; RATS;
D O I
10.1016/j.neulet.2017.11.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined whether lithium carbonate (Li2CO3, 100 mg/L) is able to prevent memory impairment induced by scopolamine. Moreover, we evaluated the effects of lithium on anxiety-like behavior and acetylcholinesterase activity in adult zebrafish. We demonstrated that lithium prevents the memory impairment induced by scopolamine, decreases exploration and increases the activity of acetylcholinesterase in zebrafish. Collectively, this contributes to a better understanding of the pharmacology of lithium, its interaction with cholinergic neuro-transmission, and its possible application to therapeutic treatments aimed at improving cognition.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 29 条
[1]   Amyloid beta 25-35 impairs reconsolidation of object recognition memory in rats and this effect is prevented by lithium carbonate [J].
Alvarez-Ruiz, Yarummy ;
Carrillo-Mora, Paul .
NEUROSCIENCE LETTERS, 2013, 548 :79-83
[2]  
[Anonymous], INT J ALZHEIMERS DIS
[3]   Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety [J].
Bencan, Zachary ;
Sledge, Damiyon ;
Levin, Edward D. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 94 (01) :75-80
[4]  
BETZ H, 1980, J PHYSIOL-LONDON, V302, P197
[5]   Drug treatments in Alzheimer's disease [J].
Briggs, Robert ;
Kennelly, Sean P. ;
O'Neill, Desmond .
CLINICAL MEDICINE, 2016, 16 (03) :247-253
[6]   Y-Maze memory task in zebrafish (Danio rerio): The role of glutamatergic and cholinergic systems on the acquisition and consolidation periods [J].
Cognato, Giana de P. ;
Bortolotto, Josiane W. ;
Blazina, Ana R. ;
Christoff, Raissa R. ;
Lara, Diogo R. ;
Vianna, Monica R. ;
Bonan, Carla D. .
NEUROBIOLOGY OF LEARNING AND MEMORY, 2012, 98 (04) :321-328
[7]   Acetylcholinesterase Inhibitors: Pharmacology and Toxicology [J].
Colovic, Mirjana B. ;
Krstic, Danijela Z. ;
Lazarevic-Pasti, Tamara D. ;
Bondzic, Aleksandra M. ;
Vasic, Vesna M. .
CURRENT NEUROPHARMACOLOGY, 2013, 11 (03) :315-335
[8]   Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics [J].
Deardorff, William James ;
Grossberg, George T. .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (01) :17-32
[9]   Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine [J].
Deiana, Serena ;
Harrington, Charles R. ;
Wischik, Claude M. ;
Riedel, Gernot .
PSYCHOPHARMACOLOGY, 2009, 202 (1-3) :53-65
[10]   Oxidative stress mediates tau-induced neurodegeneration in Drosophila [J].
Dias-Santagata, Dora ;
Fulga, Tudor A. ;
Duttaroy, Atanu ;
Feany, Mel B. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (01) :236-245